Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer

The aim of this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial ovarian cancer (EOC). Patients with recurrent or persistent EOC who had measurable disease and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kang, Heeseok, Kim, Tae-Joong, Choi, Chel Hun, Lee, Jeong-Won, Lee, Je-Ho, Bae, Duk-Soo, Kim, Byoung-Gie
Format: Artigo
Jezik:Inglês
Izdano: The Korean Academy of Medical Sciences 2009
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752782/
https://ncbi.nlm.nih.gov/pubmed/19794997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.5.945
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki